{"url_path":"/sec/pmi/8-k/2026-05-21/item-3-01","section_key":"item-3-01","section_title":"Item 3.01 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-21","source_url":"https://www.sec.gov/Archives/edgar/data/2030617/0001829126-26-005568-index.html","accession_number":"0001829126-26-005568","cik":"0002030617","ticker":"PMI","issuer_name":"Picard Medical, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/2030617/0001829126-26-005568-index.html","primary_entity_key":"0002030617","primary_entity_name":"Picard Medical, Inc."},"word_count":388,"has_tables":true,"body_markdown":"**Item 3.01.**\n**Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.**\n\n \n\nOn May 15, 2026, the Company\nreceived a written notice (the “May 15 Notice”) from the NYSE American LLC (the “NYSE American”) indicating that\nthe Company is not in compliance with the NYSE American continued listing standards set forth in Section 1003(a)(i) of the NYSE American\nCompany Guide (the “Company Guide”), which requires a listed company to have stockholders’ equity of at least of $2.0\nmillion if it has reported losses from continuing operations and/or net losses in two of its three most recent fiscal years. The May 15\nNotice states that the Company reported a stockholders’ deficit of approximately $1.4 million as of March 31, 2026 and has incurred\nlosses from continuing operations and/or net losses in its three most recent fiscal years ended December 31, 2025.\n\n \n\nAdditionally, as previously disclosed, on May\n8, 2026, the Company received a notice that it was not in compliance with Section 1003(a)(ii) (the “May 8 Notice,” and together\nwith the May 15 Notice, the “Notices”). In connection with the Notices, the\nCompany must submit a plan (the “Plan”) to the NYSE American by June 7, 2026, advising of actions it has taken or will take\nto regain compliance with the continued listing standards by November 8, 2027.\n\n \n\nThe Company is preparing its Plan in accordance\nwith the June 7, 2026 deadline. If NYSE American accepts the Company’s Plan, the Company will be able to continue its listing during\nthe Plan period and will be subject to continued periodic review by the NYSE American staff. If the Plan is not submitted, not accepted,\nor is accepted but the Company is not in compliance with the continued listing standards by November 8, 2027, or if the Company does not\nmake progress consistent with the Plan during the Plan period, the Company will be subject to delisting procedures as set forth in the\nCompany Guide.\n\n \n\nThe Notice has no immediate effect on the listing\nor trading of the Company’s common stock, which will continue to trade on the NYSE American under the symbol “PMI” with\nthe added designation of “.BC” (which was applied following the May 8 Notice). The Notice does not affect the Company’s\nongoing business operations or its reporting requirements with the SEC."}